Related Experiment Video
Updated: Nov 26, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Characterization of Deaths from Cirrhosis of the Liver in Cuba, 1987-2017
Insights
Liver cirrhosis mortality in Cuba is increasing, particularly in men and older adults, with nonalcoholic cirrhosis being the leading cause. Forecasts predict continued gradual increases in death rates.
Area of Science:
- Public Health
- Epidemiology
- Gastroenterology
Background:
- Liver cirrhosis is an irreversible, chronic liver disease representing the final stage of various liver conditions.
- It is a significant global health burden, ranking as the 11th leading cause of death worldwide.
- In Cuba, chronic liver diseases, including cirrhosis, have been a leading cause of mortality for decades, with consistently rising rates.
Purpose of the Study:
- To characterize deaths due to liver cirrhosis in Cuba between 1987 and 2017.
- To analyze mortality trends, risk factors, and etiological classifications of liver cirrhosis deaths.
Main Methods:
- An ecological time-series study was conducted using Cuba's national mortality database (1987-2017).
- Data included deceased individuals with cirrhosis as the underlying cause of death.
- Mortality rates (crude and age-adjusted) were calculated by age, sex, and etiology, with trend analysis and forecasts performed.
Main Results:
- The crude mortality rate from liver cirrhosis was 9.0 per 100,000 population over the study period.
- Mortality rates and relative risk of death were significantly higher in men and individuals aged 75 years and older.
- Nonalcoholic cirrhosis was the predominant cause, accounting for 71.6% of deaths, and mortality rates showed a progressive increase, with forecasts indicating continued rise.
Conclusions:
- Deaths from liver cirrhosis represent a substantial public health challenge in Cuba.
- The observed upward mortality trend, higher risk in men and older adults, and the prevalence of nonalcoholic cirrhosis warrant further investigation and targeted public health strategies.
Abstract:
INTRODUCTION Cirrhosis of the liver is a chronic disease that is widespread and irreversible. It represents the fi nal stage of numerous diseases that affect the liver. By the end of 2017, it was the 11th most common cause of death, with a loss of 41.4 million years of disability-adjusted life years, which represent 2.1% of the total years of life lost in the global mortality burden. In Cuba, cirrhosis and other chronic liver diseases have been among the top 10 causes of death for several decades, their rates consistently increasing, from 576 deaths in 1970 (6.7 per 100,000 population) to 1738 in 2017 (15.5 per 100,000 population), with a risk of death that is 4.6 times higher in men. OBJECTIVE Characterize deaths from cirrhosis of the liver in Cuba from 1987 to 2017. METHODS An ecological time-series study was conducted for 1987 to 2017 using information obtained from the mortality database of the Medical Records and Health Statistics Bureau of Cuba's Ministry of Public Health. The study universe consisted of all deceased persons in the country whose underlying cause of death was cirrhosis of the liver. Both general mortality rates and specifi c mortality were calculated by age group, sex and etiological classifi cation using adjusted and crude rates. Rates were age-adjusted using the direct method, and the population from the 2002 Census of Population and Housing was considered as the standard population. Percentages and means were also calculated according to selected variables and the relative risk of death due to the disease according to sex, age group and etiological classifi cation. The trend and forecast for mortality rates were estimated for this disease. RESULTS The crude mortality rate from cirrhosis of the liver was 9.0 per 100,000 population for the period. Those aged ≥75 years had the highest risk of death (48.3 per 100,000 population). The crude and adjusted mortality rates were almost double for men (12.4 vs. 5.6 and 11.7 vs. 5.6 per 100,000 population, respectively), as was the total relative risk of death, which was 2.2 times higher. Nonalcoholic cirrhosis accounted for 71.6% of deaths. By the end of 2017, risk of death from cirrhosis had climbed to 14.8 per 100,000 population (adjusted rate: 10.6 per 100,000 population), a signal that mortality had progressively increased over the 31 years analyzed. In addition, forecasts predict that death rates will continue their gradual increase, reaching 19.2 per 100,000 population in 2025. CONCLUSIONS Deaths from cirrhosis of the liver constitute a substantial health burden in Cuba. The upward trend and forecast, in addition to increased risk of mortality in men and older adults, are similar to those reported internationally. The fi nding that most of these deaths result from nonalcoholic cirrhosis should be further studied, as formulation of effective public health strategies depends largely on attaining a better understanding of the etiology, progression and social determinants of the disease. KEYWORDS Liver cirrhosis, alcoholic liver cirrhosis, fatty liver, mortality, Cuba.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Kubler Ross's Stages of Dying
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

